TradeUP Acquisition amends stock purchase agreement; Estrella to issue 250K preferred shares as commitment fee

Estrella Immunopharma, Inc.

Amendment to Common Stock Purchase Agreement with White Lion Capital, dated April 26, 2023.
Commitment fee changed: Estrella Biopharma to issue 250,000 Series A preferred shares ($250,000 value) to White Lion immediately prior to merger closing.
Amendment modifies Sections 7.1(v) and 10.1(ii) of the original agreement; all other terms unchanged.

Key facts

Extracted from this filing and checked against the source text.

Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.9

Estrella Immunopharma, Inc. amended Amendment to the Common Stock Purchase Agreement with White Lion Capital, LLC valued at $250,000 (effective 2023-04-26).

Action: amendment
Agreement: equity purchase
Counterparty: White Lion Capital, LLC
Value: $250,000
Effective: 2023-04-26

Exact text from the filing

Pursuant to the Amendment, the Company agrees that it will, immediately prior to the closing of the proposed business combination with Estrella Biopharma, Inc. (“Estrella”), cause Estrella to issue to White Lion an aggregate of 250,000 shares of Estrella’s Series A preferred stock, par value $0.0001 per share, which the parties have acknowledged has a value of $250,000.

View on SEC.gov

Browse all material agreements →

Estrella Immunopharma, Inc. filing history →

Source: SEC EDGAR

accession 0001575872-23-000629

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.